氯胺酮在全关节置换术中疗效与安全性的系统综述
本系统综述检索了2020年前关于氯胺酮在初次全髋和全膝关节置换术中应用的研究,最终纳入7项高质量研究进行定性评估和直接比较荟萃分析。高质量证据表明术中氯胺酮可减少术后阿片类药物消耗,4/7项研究发现其减轻术后疼痛,且不增加不良事件,可能减少术后恶心呕吐(RR 0.68;95% CI 0.50-0.92)。
要点
- 高质量证据支持术中氯胺酮减少全髋和全膝关节置换术后阿片类药物消耗。
- 4/7项研究发现氯胺酮减轻术后疼痛,且不增加不良事件。
- 氯胺酮可能减少术后恶心呕吐(RR 0.68;95% CI 0.50-0.92)。
核心结论
- 高质量证据支持在初次全髋和全膝关节置换术中术中使用氯胺酮以减少术后阿片类药物消耗。
- 多数研究发现氯胺酮减轻术后疼痛、恶心和呕吐。
- 中等质量证据支持氯胺酮的安全性,但作者指出对术后谵妄风险患者(如老年人)应谨慎使用。
研究设计与样本
- 检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials数据库中2020年前发表的关于氯胺酮在全髋和全膝关节置换术中应用的研究。
- 所有纳入研究经过定性评估和定量同质性检验,随后进行系统综述和直接比较荟萃分析以评估氯胺酮的疗效和安全性。
- 对136篇文献进行批判性评估后,纳入7项高质量研究进行分析。
主要发现
- 高质量证据表明术中氯胺酮减少术后阿片类药物消耗。
- 7项研究中有4项发现氯胺酮减轻术后疼痛。
- 术中氯胺酮与不良事件增加无关,可能减少术后恶心呕吐(相对风险[RR] 0.68;95% CI 0.50-0.92)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ketamine is administered intraoperatively to treat pain associated with primary total hip (THA) and knee arthroplasty (TKA). The purpose of this study was to evaluate the efficacy and safety of ketamine in primary THA and TKA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons (AAHKS), American Academy of Orthopaedic Surgeons (AAOS), Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management (ASRA). METHODS: The MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases were searched for studies published prior to 2020 on ketamine in THA and TKA. All included studies underwent qualitative assessment and quantitative homogeneity testing followed by a systematic review and direct comparison meta-analysis to assess the efficacy and safety of ketamine. After a critical appraisal of 136 publications, 7 high-quality studies were included for analyses. RESULTS: High-quality evidence demonstrates that intraoperative ketamine decreases postoperative opioid consumption. Four of 7 studies found that ketamine reduces postoperative pain. Intraoperative ketamine is not associated with an increase in adverse events and may reduce postoperative nausea and vomiting (relative risk [RR] 0.68; 95% CI 0.50-0.92). CONCLUSION: High-quality evidence supports the use of ketamine intraoperatively in THA and TKA to reduce postoperative opioid consumption. Most studies found ketamine reduces postoperative pain, nausea, and vomiting. Moderate quality evidence supports the safety of ketamine, but it should be used cautiously in patients at risk for postoperative delirium, such as the elderly.
引用
- Hannon CP, Fillingham YA, Gililland JM, et al. A Systematic Review of the Efficacy and Safety of Ketamine in Total Joint Arthroplasty. J Arthroplasty. 2022. PMID: 36328104. doi:10.1016/j.arth.2022.10.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。